Cells for Cells ha generado conocimiento de alto nivel, reflejado en las siguientes publicaciones científicas en revistas especializadas:
| Título | Autores | Revista | Año | |
|---|---|---|---|---|
| 1 | Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial) | Jorge G. Bartolucci, Fernando J. Verdugo, Paz L. González, Ricardo E. Larrea, Ema Abarzúa, Carlos Goset, Pamela G. Rojo, Iván Palma, Rubén Lamich, Pablo A. Pedreros, Gloria Valdivia, Valentina M Lopez, Carolina Nazzal, Francisca Alcayaga, Jimena Cuenca, Matthew J Brobeck, Amit N Patel, Fernando E Figueroa, Maroun Khoury | Circulation Research | 2017 |
| 2 | Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance | Contreras-Kallens P, Terraza C, Oyarce K, Gajardo T, Campos-Mora M, Barroilhet MT, Álvarez C, Fuentes R, Figueroa F, Khoury M, Pino-Lagos K. | Annals of the New York Academy of Sciences | 2017 |
| 3 | Artificial Mitochondria Transfer: Current Challenges, Advances, and Future Applications | Andrés Caicedo, Pedro Aponte, Francisco Cabrera, Carmen Hidalgo,Maroun Khoury | Stem Cells Int. | 2017 |
| 4 | Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies. | Alcayaga-Miranda F, Cuenca J, Khoury M. | Front Immunol. | 2017 |
| 5 | Layer-by-layer approach for a uniformed fabrication of a cell patterned vessel-like construct. | Wilkens CA, Rivet CJ, Akentjew TL, Alverio J, Khoury M, Acevedo JP. | Biofabrication | 2016 |
| 6 | Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species. | Alcayaga-Miranda F, González PL, Lopez-Verrilli A, Varas-Godoy M, Aguila-Díaz C, Contreras L, Khoury M. | Oncotarget. | 2016 |
| 7 | The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases. | Luz-Crawford P, Torres MJ, Noël D, Fernaández A, Toupet K, Alcayaga-Miranda F, Tejedor G, Jorgensen C, Illanes SE, Figueroa FE, Djouad F, Khoury M. | Stem Cells. | 2016 |
| 8 | Harnessing the Angiogenic Potential of Stem Cell-Derived Exosomes for Vascular Regeneration. | Alcayaga-Miranda F, Varas-Godoy M, Khoury M. | Stem Cells Int. | 2016 |
| 9 | PPARß/δ directs the therapeutic potential of mesenchymal stem cells in arthritis | Luz-Crawford P, Ipseiz N, Espinosa-Carrasco G, Caicedo A, Tejedor G, Toupet K, Loriau J, Scholtysek C, Stoll C, Khoury M, Noël D, Jorgensen C, Krönke G, Djouad F. | Ann Rheum Dis. | 2016 |
| 10 | Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth. | Lopez-Verrilli MA, Caviedes A, Cabrera A, Sandoval S, Wyneken U, Khoury M. | Neuroscience | 2016 |
| 11 | Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis. | Alcayaga-Miranda F, Cuenca J, Martin A, Contreras L, Figueroa FE, Khoury M. | Stem Cell Res Ther. | 2015 |
| 12 | Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental Cells. | González PL, Carvajal C, Cuenca J, Alcayaga-Miranda F, Figueroa FE, Bartolucci J, Salazar-Aravena L, Khoury M. | Stem Cells Transl Med. | 2015 |
| 13 | MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers. | Duroux-Richard I, Cuenca J, Ponsolles C, Piñeiro AB, Gonzalez F, Roubert C, Areny R, Chea R, Pefaur J, Pers YM, Figueroa FE, Jorgensen C, Khoury M, Apparailly F. | Int J Mol Sc.2i | 2015 |
| 14 | Long-term results of intracoronary transplantation of autologous bone marrow cells in dilated cardiomyopathy. | Bartolucci J, Verdugo FJ, Carrion F, Abarzúa E, Goset C, Lamich R, Sanhueza P, Pedreros P, Nazzal C, Khoury M. Figueroa FE. | Rev Med Chil. | 2015 |
| 15 | Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells. | Alcayaga-Miranda F, Cuenca J, Luz-Crawford P, Aguila-Díaz C, Fernandez A, Figueroa FE, Khoury M. | Stem Cell Res Ther.2 | 2015 |
| 16 | Stem cells for the treatment of cardiovascular diseases. An update. | Bartolucci J, Verdugo FJ, Larrea R, Carrión F, Lamich R, Pedreros P, Delgado M, Sanhueza P, Khoury M, Figueroa FE. | Rev Med Chil. 2 | 2015 |
| 17 | Innate immune system and preeclampsia | Perez-Sepulveda A, Torres MJ, Khoury M, Illanes SE. | Front Immunol. | 2012 |
| 18 | The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy. | Khoury M, Alcayaga-Miranda F, Illanes SE, Figueroa FE. | Front Immunol | 2014 |
| 19 | Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors. | Figueroa FE, Cuenca Moreno J, La Cava A | Expert Opin Drug Discov. | 2014 |
| 20 | Mesenchymal stem cell treatment for autoimmune diseases: a critical review. | Figueroa FE, Carrión F, Villanueva S, Khoury M. | Biol Res. | 2012 |
| 21 | Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway. | Luz-Crawford P, Noël D, Fernandez X, Khoury M, Figueroa F, Carrión F, Jorgensen C, Djouad F. | PLoS One2 | 2012 |
| 22 | Mesenchymal stem cells in osteoarticular pediatric diseases: an update. | Norambuena GA, Khoury M, Jorgensen C. | Pediatr Res. 2 | 2012 |